Search terms
Results 1 - 4 of 4 - ordered by :

(1) Professor Keith Fox, principal investigator, University of Edinburgh, UK, said: “These findings challenge the use of combined oral anticoagulant and antiplatelet therapy in patients with ...

Date : 28/08/2018

The off-label use of sildenafil in the treatment of residual hypertension in patients with valvular heart disease leads to worse clinical outcomes including a doubled risk of hospitalisation compared ...

Date : 29/08/2017

Increased levels of copeptin were associated with increased frequencies of typical co-morbidities of heart failure, increased severity of heart failure, and increased risk of all-cause death. ...

Date : 25/08/2012

Hot Line III - Diabetes Mellitus/Pharmacology In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of ...

Date : 31/08/2015